Venturi Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Venturi Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50	Closed	-$1.94K	–	1087
2024 Q4	$1.94K	Hold	50	–	–	﹤0.01%	1858
2024 Q3	$2.25K	Hold	50	–	–	﹤0.01%	1650
2024 Q2	$2.09K	Hold	50	–	–	﹤0.01%	1356
2024 Q1	$2.28K	Hold	50	–	–	﹤0.01%	1238
2023 Q4	$2.31K	Hold	50	–	–	﹤0.01%	1184
2023 Q3	$2.03K	Hold	50	–	–	﹤0.01%	1165
2023 Q2	$2.42K	Hold	50	–	–	﹤0.01%	888
2023 Q1	$2.46K	Buy	+50	New	+$2.57K	﹤0.01%	971

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Venturi Wealth Management's GNOM Position: Q1 2025 in Review

Venturi Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2025, closing a stake of 50 shares — an estimated $1.94K sold.

Venturi Wealth Management first reported a position in GNOM in Q1 2023 and held it in 8 quarters. The position peaked at $2.46K in Q1 2023. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2025.

Venturi Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
Venturi Wealth Management sold 50 Global X Genomics & Biotechnology ETF shares in Q1 2025, an estimated $1.94K.
Venturi Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q1 2023 and held it in 8 quarters.
Venturi Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $2.46K in Q1 2023.
60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.